ResearcherNorthwestern UniversityNo recent work listed
Suneel Deepak Kamath
Matched on ORCID iD 0000-0003-0117-366X; OpenAlex author ID A5023582019. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2020: 1 paper · 2021: 1 paper · 2022: 1 paper
Papers 3
- XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancer. Co-author DOI 10.1073/pnas.2116764119↗
- Trials and tribulations of pancreatic cancer immunotherapy. Co-author DOI 10.1016/j.canlet.2021.01.031↗
- Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study. Co-author DOI 10.1634/theoncologist.2019-0473↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniel R. Principe · 2 shared papers, 2021–2022 · strength 0.30
- Ajay Nmn Rana · 2 shared papers, 2021–2022 · strength 0.30
- Hidayatullah G. Munshi · 2 shared papers, 2021–2022 · strength 0.30
- Murray Korc · 1 shared paper, 2021 · strength 0.17
- Sheetal Mehta Kircher · 1 shared paper, 2020 · strength 0.13
- Aparna Kalyan · 1 shared paper, 2020 · strength 0.13
- Halla Sayed Nimeiri · 1 shared paper, 2020 · strength 0.13
- Al B. Benson · 1 shared paper, 2020 · strength 0.13
- Mary F. Mulcahy · 1 shared paper, 2020 · strength 0.13
- Thao D. Pham · 1 shared paper, 2022 · strength 0.13
- Dinesh Thummuri · 1 shared paper, 2022 · strength 0.13
- Patrick W. Underwood · 1 shared paper, 2022 · strength 0.13
- Jose Gilberto Trevino · 1 shared paper, 2022 · strength 0.13
- Daohong Zhou · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.